Feishen Lin

400 total citations
10 papers, 231 citations indexed

About

Feishen Lin is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Feishen Lin has authored 10 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Feishen Lin's work include Tuberculosis Research and Epidemiology (5 papers), Infectious Diseases and Tuberculosis (3 papers) and Mycobacterium research and diagnosis (3 papers). Feishen Lin is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Infectious Diseases and Tuberculosis (3 papers) and Mycobacterium research and diagnosis (3 papers). Feishen Lin collaborates with scholars based in China, Taiwan and Czechia. Feishen Lin's co-authors include Zhanjun Zhang, Lan Yao, Yidian Liu, Xia Zhang, Gang Liu, Meiying Wu, Xin Liu, Shenjie Tang, Xiaohui Hao and Jin Gu and has published in prestigious journals such as PLoS ONE, Clinical Chemistry and European Respiratory Journal.

In The Last Decade

Feishen Lin

9 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feishen Lin China	5	184	93	60	53	18	10	231
Sunish Shah United States	8	148 0.8×	105 1.1×	49 0.8×	34 0.6×	18 1.0×	35	250
Caryn M. Upton South Africa	9	127 0.7×	80 0.9×	33 0.6×	26 0.5×	24 1.3×	24	213
Patricia Pecora Fulco United States	10	180 1.0×	75 0.8×	27 0.5×	31 0.6×	21 1.2×	27	275
Hyungseok Kang South Korea	8	255 1.4×	187 2.0×	105 1.8×	41 0.8×	9 0.5×	14	304
Minh-Vu H Nguyen United States	10	185 1.0×	150 1.6×	40 0.7×	15 0.3×	23 1.3×	23	253
Sias Scherger United States	9	107 0.6×	132 1.4×	19 0.3×	43 0.8×	7 0.4×	22	246
Tilman Lingscheid Germany	10	114 0.6×	71 0.8×	55 0.9×	49 0.9×	42 2.3×	24	279
Synne Jenum Norway	15	328 1.8×	246 2.6×	122 2.0×	112 2.1×	16 0.9×	34	461
Derek Cocker United Kingdom	8	96 0.5×	48 0.5×	69 1.1×	27 0.5×	16 0.9×	23	229
Liliana Preoțescu Romania	9	113 0.6×	206 2.2×	24 0.4×	40 0.8×	17 0.9×	25	353

Countries citing papers authored by Feishen Lin

Since Specialization

Citations

This map shows the geographic impact of Feishen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feishen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feishen Lin more than expected).

Fields of papers citing papers by Feishen Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feishen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feishen Lin. The network helps show where Feishen Lin may publish in the future.

Co-authorship network of co-authors of Feishen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Feishen Lin. A scholar is included among the top collaborators of Feishen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feishen Lin. Feishen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Guo, Jing, Xuebing Feng, Jiayun Pang, et al.. (2025). Risk factors for rifampicin-susceptible and isoniazid-resistant tuberculosis in adult patients with type 2 diabetes mellitus in Nanjing. BMC Infectious Diseases. 25(1). 335–335.

Guo, Jing, et al.. (2024). Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021. BMC Infectious Diseases. 24(1). 511–511. 2 indexed citations

Wáng, Yì, Chunmei Hu, Feishen Lin, et al.. (2021). Illustration of a number of atypical computed tomography manifestations of active pulmonary tuberculosis. Quantitative Imaging in Medicine and Surgery. 11(4). 1651–1667. 9 indexed citations

Zheng, Yishan, Zhen Huang, Guo-Ping Yin, et al.. (2020). Study of the Lymphocyte Change Between COVID-19 and Non-COVID-19 Pneumonia Cases Suggesting Other Factors Besides Uncontrolled Inflammation Contributed to Multi-Organ Injury. SSRN Electronic Journal. 36 indexed citations

Lin, Feishen, Meiying Wu, Wen‐Jun Tu, et al.. (2015). A cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis treatment.. PubMed Central. 7(12). 2234–42. 8 indexed citations

Zhou, Yuhua, Feishen Lin, Zelin Cui, et al.. (2015). Correlation between Either Cupriavidus or Porphyromonas and Primary Pulmonary Tuberculosis Found by Analysing the Microbiota in Patients’ Bronchoalveolar Lavage Fluid. PLoS ONE. 10(5). e0124194–e0124194. 51 indexed citations

Tang, Shenjie, Lan Yao, Xiaohui Hao, et al.. (2014). Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. European Respiratory Journal. 45(1). 161–170. 119 indexed citations

Lin, Feishen, et al.. (1999). Comparison of clinical efficacy and adverse effects between extended-release felodipine and slow-release diltiazem in patients with isolated systolic hypertension.. PubMed. 22(1). 44–51. 1 indexed citations

Lin, Feishen, et al.. (1997). Comparison of clinical efficacy and adverse effects between extended-release felodipine and atenolol in patients with mild and moderate essential hypertension.. PubMed. 20(2). 86–93. 1 indexed citations

10.

Perel, J M, et al.. (1988). Monitoring of imipramine imi and desipramine dmi in patients with panic and phobic disorders. Clinical Chemistry. 34(6). 1262. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact